Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Schiffmann

Showing results (101-110 of 225) with videos related to

Pageof 23
Sort By:
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2020
Correction: Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Nephron|June 30, 2025
Expanded View of the Pathophysiology of Fabry DiseaseStanislav Kmoch, Martina Živná, Moran Dvela-Levitt, et al.
Human Mutation|November 4, 2004
Transfer of a mitochondrial DNA fragment to MCOLN1 causes an inherited case of mucolipidosis IVEhud Goldin, Stefanie Stahl, Adele M Cooney, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2017
Low frequency of Fabry disease in patients with common heart diseaseRaphael Schiffmann, Caren Swift, Nathan McNeill, et al.
Molecular Genetics and Metabolism|August 19, 2008
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cellsJin-Song Shen, Xing-Li Meng, David F Moore, et al.
Plos One|December 18, 2009
Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disordersLaetitia Horzinski, Aurélia Huyghe, Marie-Céleste Cardoso, et al.
JIMD Reports|November 6, 2023
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry diseasePaulina Dabrowska-Schlepp, Andreas Busch, Jin-Song Shen, et al.
Blood Cells, Molecules & Diseases|June 18, 2002
Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapyRaphael Schiffmann, Henry Mankin, James M Dambrosia, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry diseaseDavid F Moore, Ehud Goldin, Monique P Gelderman, et al.
The Journal of Biological Chemistry|November 30, 2011
Early alterations of brain cellular energy homeostasis in Huntington disease modelsFanny Mochel, Brandon Durant, Xingli Meng, et al.
Pageof 23

Showing results (101-110 of 225) with videos related to

Sort By:
Pageof 23
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 21, 2020
Correction: Assessment of plasma lyso-Gb<sub>3</sub> for clinical monitoring of treatment response in migalastat-treated patients with Fabry diseaseDaniel G Bichet, Johannes M Aerts, Christiane Auray-Blais, et al.
Nephron|June 30, 2025
Expanded View of the Pathophysiology of Fabry DiseaseStanislav Kmoch, Martina Živná, Moran Dvela-Levitt, et al.
Human Mutation|November 4, 2004
Transfer of a mitochondrial DNA fragment to MCOLN1 causes an inherited case of mucolipidosis IVEhud Goldin, Stefanie Stahl, Adele M Cooney, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 12, 2017
Low frequency of Fabry disease in patients with common heart diseaseRaphael Schiffmann, Caren Swift, Nathan McNeill, et al.
Molecular Genetics and Metabolism|August 19, 2008
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cellsJin-Song Shen, Xing-Li Meng, David F Moore, et al.
Plos One|December 18, 2009
Eukaryotic initiation factor 2B (eIF2B) GEF activity as a diagnostic tool for EIF2B-related disordersLaetitia Horzinski, Aurélia Huyghe, Marie-Céleste Cardoso, et al.
JIMD Reports|November 6, 2023
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry diseasePaulina Dabrowska-Schlepp, Andreas Busch, Jin-Song Shen, et al.
Blood Cells, Molecules & Diseases|June 18, 2002
Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapyRaphael Schiffmann, Henry Mankin, James M Dambrosia, et al.
Acta Paediatrica (Oslo, Norway : 1992)|May 28, 2008
Apoptotic abnormalities in differential gene expression in peripheral blood mononuclear cells from children with Fabry diseaseDavid F Moore, Ehud Goldin, Monique P Gelderman, et al.
The Journal of Biological Chemistry|November 30, 2011
Early alterations of brain cellular energy homeostasis in Huntington disease modelsFanny Mochel, Brandon Durant, Xingli Meng, et al.
Pageof 23